From the Jawaharlal Nehru Centre for Advanced Scientific Research, HIV-AIDS Laboratory, Bengaluru 56006, India.
the Laboratory of Molecular Virology, Division of Emerging and Transmission Transmitted Diseases, Office of Blood Review and Research, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland 20993.
J Biol Chem. 2018 Jul 27;293(30):11687-11708. doi: 10.1074/jbc.M117.815829. Epub 2018 May 17.
HIV-1 subtype C (HIV-1C) may duplicate longer amino acid stretches in the p6 Gag protein, leading to the creation of an additional Pro-Thr/Ser-Ala-Pro (PTAP) motif necessary for viral packaging. However, the biological significance of a duplication of the PTAP motif for HIV-1 replication and pathogenesis has not been experimentally validated. In a longitudinal study of two different clinical cohorts of select HIV-1 seropositive, drug-naive individuals from India, we found that 8 of 50 of these individuals harbored a mixed infection of viral strains discordant for the PTAP duplication. Conventional and next-generation sequencing of six primary viral quasispecies at multiple time points disclosed that in a mixed infection, the viral strains containing the PTAP duplication dominated the infection. The dominance of the double-PTAP viral strains over a genetically similar single-PTAP viral clone was confirmed in viral proliferation and pairwise competition assays. Of note, in the proximity ligation assay, double-PTAP Gag proteins exhibited a significantly enhanced interaction with the host protein tumor susceptibility gene 101 (Tsg101). Moreover, Tsg101 overexpression resulted in a biphasic effect on HIV-1C proliferation, an enhanced effect at low concentration and an inhibitory effect only at higher concentrations, unlike a uniformly inhibitory effect on subtype B strains. In summary, our results indicate that the duplication of the PTAP motif in the p6 Gag protein enhances the replication fitness of HIV-1C by engaging the Tsg101 host protein with a higher affinity. Our results have implications for HIV-1 pathogenesis, especially of HIV-1C.
HIV-1 亚型 C(HIV-1C)可能会在 p6 Gag 蛋白中复制更长的氨基酸序列,从而产生一个额外的 Pro-Thr/Ser-Ala-Pro(PTAP)基序,该基序对于病毒包装是必需的。然而,PTAP 基序重复对于 HIV-1 复制和发病机制的生物学意义尚未通过实验验证。在对来自印度的两个不同临床队列的选择 HIV-1 血清阳性、未经药物治疗的个体进行的纵向研究中,我们发现这 50 人中的 8 人携带了病毒株混合感染,这些病毒株在 PTAP 重复方面存在差异。在多个时间点对六种主要病毒准种进行常规和下一代测序,揭示了在混合感染中,含有 PTAP 重复的病毒株占主导地位。在病毒增殖和成对竞争实验中,证实了含有双重-PTAP 病毒株比遗传上相似的单一-PTAP 病毒克隆具有优势。值得注意的是,在接近连接测定中,双重-PTAP Gag 蛋白与宿主蛋白肿瘤易感性基因 101(Tsg101)表现出显著增强的相互作用。此外,Tsg101 的过表达对 HIV-1C 的增殖产生了两相效应,在低浓度下增强,而在较高浓度下仅具有抑制作用,与对 B 型株的均匀抑制作用不同。总之,我们的结果表明,p6 Gag 蛋白中 PTAP 基序的重复通过以更高的亲和力与宿主蛋白 Tsg101 结合,增强了 HIV-1C 的复制适应性。我们的结果对 HIV-1 发病机制,特别是 HIV-1C 的发病机制具有重要意义。